The following is the full transcript of an interview with Dr. Peter Marks, former head of FDA's Center for Biologics ...

The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.

A top federal health official ousted by the Trump administration denounced Health and Human Services Secretary Robert F.

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against other ...

Former Food and Drug Administration vaccine chief Dr. Peter Marks weighed in on Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s remarks about finding a cause of ...

"If you just ask me, as a scientist, is it possible to get the answer quickly? I don't see any possible way," said Dr. Peter ...

Giving people false hope is something you should never do… Giving them false hope is wrong,” Dr. Peter Marks, former head of the Food and Drug Administration’s Center for Biologics ...

Dr Peter Marks, who has been director of the FDA's Centre for Biologics Evaluation and Research (CBER) since 2016. The abrupt departure of Peter Marks as the director of the FDA's Centre for ...

The firm is adjusting its model after the previous death of a patient on high-dose NGN-401 and the recent resignation of Peter Marks from the FDA. BMO remains positive on the stock and believes ...